Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And really that isn't relevant as eventually MMTE will merge or be bought out completely and that creates shareholder value for any company that merges or takes over the company has to account for the stock meaning shareholders will get the value of the transaction.
I don't put much faith in buy vs sell transaction reporting here as MM's can make a transaction look anyway they want. For every transaction there has to be a buy and a sell and if the transaction occurs at bid it is a sell regardless if someone purchased shares on a GTC ordered
I was going for 0.0004 or maybe 0.0005. Chances are this will not up list.
i very much agree with that assessment.
jfburk, I understand, good points, but look at the bid to the sells listed, same as usual going on, news then we seem to drift lower. Something just does not add up here, as time keeps tucking by we still see a stock with no real faith th boost it up where many of feel she belongs at this junction. Nothing so far has materialistically given MMTE a firmer postion on this stage.
SPOT ON jfburk!! $MMTE$
You are dead on with this post. With the AUDITED financials coming soon these nay-sayers will finally be proven wrong. We will get the last laugh. I promise!
What will get this company to .10 is retiring about 5-9 billion shares and increasing the concessions in South America.
Too many short term thinkers ignoring what is actually going on in this company. Some seem to think that 15billion shares are the O/S when that number is closer to 6.6 billion and if you take the top end of the values of the concession and divide it by 6.6 billion you get a share valuation of over .10
RS is a sure way of dropping under 0.0001 (in this case).
why? company is diluting the chit out of MMTE. the PR comes because VERT needs liquidity to sell.
last PR was a bit too vague and the volume didn't match the needs (at least not enough)
miscalculation of the market - new try.
hence, new PR. lol
Its common sense. no other way to 10 cents. 6 months from now there will still be talk of uplist. some things NEVER change in MMTE land.
anyone notice the lack of volume today, anyone notice the absurd amount of shares for sale?
common sense has MMTE still trading at .0005/6 with no volume of yet again fluff news with seller lurking everywhere. RS is only way to 10 cents. no thats common sense.
LOL... not even close. The statements are self-explanatory and quite accurate. MMTE has no hope of uplisting with a PPS in the triple zeros. A reverse split must occur if WL seeks to uplist this forlorn stock.
THE STATEMENTS MADE IN THE POST TO WHICH THIS REPLIES SPECIOUSLY LACK ANY SUPPORT OR EVIDENCE. The statements thus render themselves without credibility. If true, the provision of PROOF of such statements would prove most appropriate; however, one must acknowledge that no proof exists to support the egregious accusations.
I am still remaining positive but with all do respect, how are we going to get to .10 to qualify for the up listing, even if we do a merger first how would we get to the .10? A lot needs to be addressed here, as usual, it still leaves us in some what of a fog, more clarification needed here with MMTE.
Who really cares if a Reverse Split is recommended. Your leverage is the same. The only danger in R/S is if the company has nothing on the go and now can go even lower in value than before.
The price goes up by the Reverse. So what if we are forced to R/S at 100:1. Instantly we are at .07 with 60 Million shares Outstanding.
Everyone's account stays the same... unless that .07 falls to .01 ... only there lies any negative??
FISHY NEWS. FRUSTRATING FUTURE.
My understanding is...With a JV each company keeps their own identity...two companies working together to get something done. (mine Lithium)
With a Merger two companies blend into one.
So uplisting ,to my way of thinking,leans toward joint venturing...but I am not an expert by any means.
I did post an article that addresses uplisting that may be a bit of help-as one of my other stocks is due to merge within the month.
Go MMTE... and thank you William!!!
Up listing means to me no present plans for buy out, but rather for father development. I'm sure that JV or RM will come prior. The problem I see is that if everything is moving forward as I hope so then the overall process may be pretty secretive considering the current situation in Chile and a fight for government contracts coming on. May be by doing this PR WL tells us as much as he can about his plans and doings. I still stay positive, and would buy more if I could. GO MMTE.
HUGE NEWS MMTE NATION !!!
heyU, would a JV or merger with one of the 2 or 3 companies we have been discussing here not take care of the uplisting immediately? IMO Junebug
ONE MORE ITEM FOR CONSIDERATION.
No larger company would consider merging or a JV with a pink. This uplist proves to me that there are plans in the works for bigger and better.
yes and the Audit firm could recommend a RS. IMO. then WL will say it was them and not him. classic. Ill look to see how the stock reacts before i make any conclusions. imo
GREAT NEWS!!! Everyone needs to realize what this means. Audited financials mean that the CLIL should be audited at the same time since it is a subsidiary of MMTE. THAT MEANS WE GET THE VALUATIONS OF THE CONCESSIONS! Now with that said it can be in one of 2 forms. Cost basis (how much MMTE paid for them) or market value (what they are worth)
ALSO, a normal audit can be done in as little as 2 weeks. However, it is tax season so hopefully the auditors aren't too busy.
!!!!! GREAT NEWS WILLIAM !! GO MMTE !!!!!
JUST GETS BETTER AND BETTER... CEO IS ON TRACK FOR
A MAJOR MOVE !!!!!!!!!!
GO MMTE !!!
; )
2 clean years of financials needed, enjoy your free shares
You mean just like MMTE has been doing since 2010 ???? W.L. mentioned up listing back in 2010 and just now is "looking" into it. LOL, I can just imagine how much longer it will be when W.L. starts "looking" into JV's/MERGER's/NI 43-101's/BUY OUTS........ LOLOL
GO MMTE !!
Quiet Spring Break morning in the market and some MM is trying to keep the action down by throwing up .0006 for beer money. Won't be long before the Wave changes direction.
Great News now that this news is out you people on the sidelines better get in we all know what news is next. GO MMTE
Only if the price was less than a dime.
YES GREAT NEWS! Mammoth Energy Group Engages_Audit_Firm for Uplisting
http://ih.advfn.com/p.php?pid=nmona&article=51735749&symbol=MMTE
7s hit, getting ready to uplist and you have 0.0005 x23,481,400
what is your target?
GO MMTE
The way I see it uplisting is going to be a long process, and JV and/or RM may happened prior to it.
What about those Billions of shares?? would that be an issue???
Once again...we have an example of William DOING what he said he was going to DO.
Go MMTE!!!
Not the news I was looking for...I'll stay on the sidelines
http://www.rbsmllp.com/services.php
Public Companies
Audit & Assurance
Tax Compliance & Advisory
Merger & Acquisitions
Internal Audit & Sox Consulting
http://www.reverse-merger.com/otcqb-and-otcqx-compared-and-contrasted/
The new OTCMarkets.com divides Issuers into three (3) levels: OTCQX; OTCQB and PinkSheets. From a fundamental perspective, Issuers on the OTCQX must be fully reporting and current in their reporting obligations with the SEC and also undergo a quality review by industry professionals. Issuers on the OTCQB must be fully reporting and current in their reporting obligations with the SEC but do not undergo additional quality review.
drews, yes .10 to qualify. Now the question is, how do we get to .10, I hope not a rs. This is why I have always said, we need better clarification from WL as we procede along this path. I am still holding 25+ millions shares but watching carefully like everyone else here as to what the real game plan is for up listing. GLTAL
come on MMTE going the wrong way. Buyers lets go
to uplist a requirement it looks like from reading is a minimun bid price of .10
Why would you have to do a r/s to uptick to the otc?
HMMM, that NEWS........might cause W.L. to BREAK his word on no RS, W.L. may have to do a RS to up list, especially if MMTE's PPS does not move up a WHOLE HELLUVA LOT. IMO !
BUT , IF MMTE can prove they have enough VALUE in the concessions , then UP LISTING could be done W/O a RS !!!
ALSO, a RS at the pps of .0007 would mean a RS of 100 to 1 or more to get to .07 so to get to .10 ..... a LARGER RS would be needed. I just HOPE MMTE's PPS can move up to .10 by itself W/O a RS !!!!
GO MMTE !
.10 bid price that is rather interesting hmmm. Not sure what to make of that.
7's split your orders up or raise them and we will move much much higher.. $MMTE$
OTCQX has a baseline set of requirements for U.S. corporations and international businesses incorporated in the U.S. Companies that are incorporated outside the U.S. should follow our international standards.
Any issuer with proprietary priced quotations published by a market maker on OTC Link will be eligible to enter the tier for which it is qualified. Companies that meet the financial requirements of NASDAQ's Capital Market Continued Listing Standards may be eligible for the higher OTCQX U.S. Premier Tier.
OTCQX U.S.
Ongoing operations (no shells, blank check or special purpose acquisition companies);
A minimum bid price of $0.10 (for preceding 90 business days);
Medical product development and commercialization. The Company recently acquired five generic oncology drugs approved and manufactured in Germany and they plan to gain approval for these drugs in the US in 2023. The Company is preparing for a pivotal Phase 3 study of an anti-cancer antibody product that is highly similar to Genentech/Roche's brand name Avastin (bevacizumab), the Company has licensed a needle-free jet injector for drug delivery, and the Company is in the pre-clinical stages of development of a gene therapy product candidate based on the delivery of a human alpha-Klotho gene and protein to prevent and/or treat neurodegenerative diseases such as Alzheimer's and Lou Gehrig's disease (ALS). Other product candidates will stem from these platform technologies of pharmaceuticals, biologics, and gene therapy.
The Company's medical R&D facilities are in the U.S. (near the University of Nebraska Medical Center, Omaha, Nebraska) and in Barcelona, Spain (Autonomous Universitat de Barcelona). Each R&D facility is comprised of over 4,000 sq ft of R&D and office space, currently leased and equipped with research equipment, incubators, tissue culture facilities for production of plasmid DNA, HEPA-filtered hoods for aseptic handling, and testing equipment (PCR, spectrophotometers, microscopes, etc). The generic oncology drugs are manufactured in Germany. With future funding, the Company plans to acquire or build a GMP manufacturing facility to supply novel plasmid DNA ("transgenes") to be used in gene therapy programs, to provide contract manufacturing revenue, and for commercial product manufacturing.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |